T cells are both producers and consumers of cytokines, and autocrine cytokine signaling plays a critical role in T cell immunity. IL-15 is a homeostatic cytokine for T cells that also controls inflammatory immune responses. An autocrine role of T cell-derived IL-15, however, remains unclear. Here we examined IL-15 expression and signaling upon effector T cell differentiation in mice, and, surprisingly, found that CD4 T cells did not express IL-15. CD4 T cells lacked Il15 gene reporter activity, did not contain IL-15 transcripts, and did not produce IL-15Rα, the proprietary IL-15 receptor required for IL-15 trans-presentation. Moreover, IL-15 failed to inhibit Th17 cell differentiation and failed to generate Foxp3 + Treg cells in vitro. IL-2, which utilizes the same IL-2Rβ/γc receptor complex, however, successfully did so. Exogenous IL-15 only exerted bioactivity and controlled T cell differentiation when it was trans-presented by IL-15Rα. Consequently, IL-15Rα-bound IL-15, but not free IL-15, suppressed Th17 cell differentiation and induced Treg cell generation. Collectively, these results reveal the absence of an IL-15 autocrine loop in CD4 T cells and strongly suggest that IL-15 trans-presentation by non-CD4 T cells is the primary mechanism via which IL-15 controls CD4 effector T cell differentiation.
Introduction
A primary function of CD4 effector T cells is the production of cytokines [1] . Depending on the cytokines they express, CD4 T cells can be classified into different subsets with distinct functions [2] . In a simplified version, IFNγ-producing CD4 T cells are known as Th1 cells, whereas IL-4-and IL-5-producing CD4 T cells are referred to as Th2 cells [3] . CD4 T cells that express the pro-inflammatory cytokine IL-17 are designated as Th17 cells [4, 5] , and they recently came into the limelight because of their role in exacerbating autoimmunity [6] . While T cell-derived cytokines usually act in a paracrine fashion, cytokines also feedback onto CD4 T cells themselves. Thus, T cell immunity is orchestrated by a complex network of both cis-and trans-acting cytokines [2] .
IL-15 is a critical cytokine in T cell immunity [7, 8] . Its importance is illustrated, among others, in IL-15-deficient mice which display severe defects in CD8 effector memory cell generation and T cell effector function [9, 10] . However, IL-15-deficiency can also exacerbate autoimmune neuroinflammation [11] [12] [13] [14] , so that IL-15′s involvement in inflammatory diseases is evident, but its exact role as a pro-or antiinflammatory agent remains unclear. Moreover, the cellular source of IL- 15 is not yet fully identified, and both T cell-intrinsic and -extrinsic expression of IL-15 have been reported. On one hand, IL-15 is proposed to be expressed by stromal cells, myeloid cells, and medullary thymic epithelial cells, but not by T cells themselves [15, 16] . On the other hand, earlier studies identified IL-15 mRNA transcripts in human T cells [17] , so that ex vivo isolated human T cells were proposed to survive and proliferate in vitro by an autocrine loop of IL-15 expression and signaling [18] . IL-15 gene transcription was also reported in murine T cells [12, 19] , and development of T cell leukemia in IL-15-transgenic mice was shown to be induced through autocrine IL-15 expression and signaling in CD8 T cells [20] . In the same vein, CD4 T cells from IL-15-deficient mice exhibited dysregulated effector functions, which supported an autocrine role for IL-15 in effector T cell differentiation [12, 17] . Thus, CD4 T cell-derived IL-15 is potentially an important mechanism that controls CD4 T helper function. However, whether this is the case in vivo is unclear, and what consequences it might have on effector T cell differentiation still needs to be addressed.
Assessing this question is particularly important because IL-15 utilizes the same IL-2Rβ/γc cytokine receptor complex as IL-2 for ligand binding and signaling [10] . IL-2 is produced by activated T cells and plays critical roles in many aspects of T cell biology, including Th1/Th2 effector T cell differentiation, Foxp3 + T regulatory cell generation, and CD8 cytolytic T cell activities [21] . Thus, competing for the same receptor complex with IL-15 could diminish IL-2Rβ/γc availability for IL-2 and result in impaired IL-2 signaling and downstream effector function. IL-2 expression is terminated by IL-2 receptor signaling as a negative regulatory feedback mechanism [22] . Because IL-15 also activates IL-2Rβ/γc signaling, IL-15 could induce premature termination of IL-2 expression and interfere with IL-2-dependent T cell responses. Under such a scenario, autocrine IL-15 would be detrimental for IL-2 expression. Moreover, IL-2Rβ/γc signaling suppresses pro-inflammatory IL-17 production [23] , so that IL-2 receptor signals are antiinflammatory by inhibiting Th17 cell differentiation [24] . Whether autocrine IL-15 also constrains Th17 polarization is an interesting issue, because it could explain the anti-inflammatory effects of IL-15 [25] . A role for CD4 T cell-derived IL-15 in Th17 cell differentiation had been previously proposed [12] . However, the molecular mechanisms that drive IL-15 expression in CD4 T cells and its potential effects on other helper T cell subsets remain unresolved.
Here, we assessed IL-15 expression and signaling in naïve and effector CD4 T cells. Surprisingly, and in contrast to previous studies [12, 26] , Il15 gene reporter mice analysis and quantitative real-time RT-PCR results failed to provide evidence for IL-15 expression in CD4 T cells. Moreover, CD4 T cells did not express IL-15Rα, which is the highaffinity receptor required for IL-15 trans-presentation to IL-2Rβ/γc expressing target cells [27, 28] , and for optimal IL-15 signaling in cis [20, 29, 30] . Thus, we propose that it is unlikely that IL-15 exerts autocrine effects on CD4 effector T cells. Moreover, we found that recombinant IL-15 alone lacked bioactivity, as it was unable to drive Foxp3 + Treg cell generation or suppress Th17 cell differentiation in vitro, even as it induced robust STAT5 phosphorylation in activated CD4 T cells. IL-15 complexed with IL-15Rα, however, effectively suppressed generation of pro-inflammatory Th17 cells and induced Foxp3 + Treg cell differentiation. These results suggested that IL-15 trans-presented by IL-15Rα is the biologically relevant form of IL-15. Consequently, this study documents IL-15 as potent regulator of CD4 effector cell differentiation whose bioactivity is controlled and constrained by IL-15Rα trans-presentation.
Materials and methods

Animals
C57BL/6 (WT) mice were obtained from the Jackson Laboratory or Charles River. EmGFP/IL-15 reporter mice were provided by Leo Lefrancois [19] . Il15 -/-and Il15ra -/-mice were previously described [9, 31] . IL-2Rβ Tg mice were generated by cloning a murine Il2rb cDNA under the control of a human CD2 mini-cassette and injection into fertilized B6 oocytes. All animal experiments were approved by the Animal Care and Use Committee (ACUC) of the National Cancer Institute, NIH. Mice were cared for in accordance with NIH guidelines.
Flow cytometry
Data were analyzed on the FACSCalibur, FACSAria, or LSRII (BD) using software designed by the Division of Computer Research and Technology at the NIH. Live cells were gated using forward scatter exclusion of dead cells and staining with propidium iodide. iNKT cells were detected using PBS-57-loaded CD1d tetramer staining. For intracellular cytokine staining, cells were first surface stained, fixed with IC fixation buffer, and then permeabilized using the intracellular permeabilization buffer (eBioscience), according to the manufacturer's instructions. pSTAT5 expression was determined following 30 min of stimulation with IL-2, IL-15 or IL-15/IL15Rα and intracellular staining as previously described [32] . For Foxp3 transcription factor staining, in vitro differentiated cells were fixed and permeabilized using a Foxp3 intracellular staining kit, following the manufacturer's instruction (eBioscience).
Antibodies
The antibodies with following specificities were used; CD4 (GK1.5, Tonbo), CD8 (53.67, Tonbo), CD11c (HL3, BD), CD11b (M1/70, eBioscience), TCRβ (H57-597, BD), NK1.1 (PK136, eBioscience), γδTCR (GL3, Biolegend), CD44 (IM7, eBioscience), CD122 (TMβ1, BD), CD62L (MEL-14, eBioscience), IL-15Rα (DNT15Rα, eBioscience), IL-2Rα (3C7, Biolegend), γc (4G3, BD), IL-17 (eBio17B4, eBioscience), IFNγ (XMG1.2, Biolegend), pSTAT5 (clone 47, BD), Foxp3 (MF23, BD). Fluorochrome-conjugated CD1d tetramers loaded with PBS-57 were obtained from the NIH tetramer facility (Emory University, Atlanta, GA).
In vitro T cell differentiation
Naïve CD4 T cells were electronically sorted by gating on CD44 
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-were used to define naïve CD4 T cells. Sorted cells were stimulated with plate-bound anti-CD3/CD28 antibodies and cultured under skewing conditions for 5 days. Th1 condition: recombinant mouse IL-12 (10 ng/ml) and anti-IL-4 antibodies (10 µg/ml, Biolegend). Th2 condition: anti-IFNγ antibodies (10 µg/ml), and recombinant mouse IL-4 (20 ng/ml, Peprotech); Th17 conditions: anti-IL-4 (10 µg/ml) and anti-IFNγ antibodies (10 µg/ml), recombinant human TGFβ (5 ng/ml, Peprotech) and recombinant mouse IL-6 (30 ng/ml, Peprotech). Where indicated, recombinant human IL-15 (25 ng/ml, Peprotech), recombinant human IL-2 (25 ng/ml, Peprotech), or recombinant mouse IL-15/IL-15Rα complex (100 ng/ml, eBioscience) was added to the cell cultures. For cytokine production analysis, cultures were stimulated for 3 h with PMA/ionomycin (Sigma) and Brefeldin A (eBioscience) for 3 h, followed by intracellular staining and flow cytometric analysis.
Quantification of soluble IL-15Rα proteins
Naïve CD4 T cells were enriched from the LN of B6 mice and stimulated with 1 μg/ml plate-bound anti-CD3/CD28 antibodies for 5 days under Th1 or Th17 skewing conditions. Culture supernatants were harvested and soluble IL-15Rα contents were determined using a mouse IL-15Rα DuoSet ELISA kit (R & D Systems).
Quantitative real time PCR
Total RNA was isolated using RNeasy (Qiagen) or Nucleospin (Machery-Nagel). RNA was reverse transcribed into cDNA by oligo(dT) priming with the QuantiTect reverse transcription kit (Qiagen). Quantitative RT-PCR (qRT-PCR) was performed with the QuantiTect SYBR green detection system (Qiagen) and analyzed on an ABI PRISM 7900HT (Life Technologies) as previously described [33] . The following primers were used for qRT-PCR: IL-15 (5′-AATCCACCTTGAC-ACATGGC-3′; 5′-AGGCTGGTTATCTGCTGACA-3′), RORγt (5′-GCTGT-CCTGGGCTACCCTACTGA-3′; 5′-TGCGGCGGAAGAAGCCCTTG), RPL13 (5′-CGAGGCATGCTGCCCCACAA-3′; 5′-AGCAGGGACCACCAT-CCGCT-3′) and T-bet (5′-AGCTGCGCGCCTATCCAACG; 5′-TCCTTAG-GGCTGGGGCGACG-3′).
Statistical analysis
Statistical differences were calculated using a Student's two-tailed ttest. P values of less than 0.05 were considered statistically significant. * p < 0.05, * * p < 0.01, * * * p < 0.001, NS not significant. All calculations were performed using GraphPad Prism.
Results
Lack of evidence for IL-15 expression in naïve and effector CD4 T cells
To identify potential autocrine effects of IL-15 in CD4 T cells, we utilized emerald GFP (EmGFP)-Il15 reporter mice to map IL-15 gene expression [19] . While EmGFP reporter proteins were robustly expressed in CD8 LN T cells and other hematopoietic origin cells ( 
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-effector memory phenotype CD4 T cells (Fig. 1B top) . In contrast, we found that both naïve (CD44 lo IL-2Rβ examined IL-15 reporter activity in activated CD4 T cells that have been polarized in vitro under Th1 or Th17 skewing conditions. Strikingly, and in marked contrast to freshly isolated NK cells, IL-15 reporter expression was virtually absent in CD4 effector T cells (Fig. 1C) . In agreement with the lack of EmGFP reporter protein expression, we also did not detect discernable amounts of IL-15 mRNA transcript in Th1 and Th17 cells (Fig. 1D) . Thus, contrary to previous reports [12, 26] , our results indicate that IL-15 expression is not a feature associated with CD4 T cells, and therefore argue against an autocrine role for IL-15 in CD4 T cells.
CD4 T cells are refractory to IL-15 stimulation
To directly assess if there would be cell-intrinsic effects of CD4 T cell-derived IL-15, we stimulated naïve CD4 T cells from WT and IL-15-deficient mice (Il15 -/-) under Th17 skewing conditions and examined their IL-17 production. IL-2 signaling downregulates IL-17 expression [23] , and IL-15 reportedly acts the same way on Th17 cells [12, 26] . If there would be autocrine effects of IL-15, we expected to see increased IL-17 expression in Il15 -/-CD4 T cells. However, this was not the case, and we did not to find any significant differences in IL-17 production between WT and Il15 -/-Th17 cells ( Fig. 2A) . Additionally, there was no difference in IL-17 production between in vitro differentiated WT and Il15ra -/-CD4 T cells (Supplemental Fig. 2A ).
Because the absence of IL-15 did not alter Th17 cell generation, next, we wished to examine if the presence of IL-15 would affect IL-17 expression. To this end, we stimulated naïve WT CD4 T cells with platebound anti-CD3/CD28 antibodies under Th17 skewing conditions in the presence or absence of recombinant IL-15. As previously reported, IL-2 potently inhibited Th17 cell generation (Fig. 2B) [23] . IL-15, however, did not affect IL-17 production under the same conditions (Fig. 2B ). Inducing Th17 cell differentiation by stimulating with irradiated antigen presenting cells (APCs) also did not potentiate any effects of IL-15, so that IL-17 production remained unaffected by addition of IL-15 or the expression of IL-15Rα on APCs (Supplemental Fig. 2B ). These results revealed that suppression of IL-17 production is a cytokine-specific effect that is downstream of IL-2, but not of IL-15 signaling. Collectively, these findings indicated that in vitro Th17 differentiation is refractory to recombinant IL-15 stimulation.
IL-2Rβ overexpression promotes IL-15 signaling in CD4 T cells
IL-15 signaling requires IL-2Rβ expression, but CD4 T cells express very low levels of IL-2Rβ relative to other lymphocyte populations, such as CD8 T cells, NK cells, and iNKT cells (Supplemental Fig. 3) . Thus, we asked if insufficient IL-2Rβ expression was the reason that IL-15 failed to suppress Th17 cell differentiation. To address this possibility, we generated transgenic mice expressing a murine IL-2Rβ cDNA under the control of human CD2 promoter/enhancer elements (IL-2Rβ Tg ). CD4 T cells from IL-2Rβ
Tg mice expressed high levels of surface IL-2Rβ (Fig. 3A) . Transgenic IL-2Rβ proteins were functional because they conferred dramatically increased IL-2 and IL-15 responsiveness to IL-2Rβ Tg CD4 T cells, as demonstrated by the marked increase of STAT5 phosphorylation upon IL-2 and IL-15 signaling (Fig. 3B, C) (Fig. 3D ). These results indicated that IL-15′s inability to suppress IL-17 production is not because of limited quantities of IL-2Rβ proteins on CD4 T cells.
IL-15 trans-presented by IL-15Rα suppresses IL-17 production in CD4 T cells
IL-15 differs from other γc cytokines as it utilizes a mechanism known as trans-presentation for ligand binding and signaling [34] . IL-15 binds to IL-15Rα with high-affinity [35, 36] , and IL-15 that is transpresented by IL-15Rα exerts enhanced bioactivity compared to IL-15 alone [37, 38] . To examine if IL-15 trans-presentation is required to suppress IL-17 expression, we assessed surface IL-15Rα expression on Th17 cells. IL-15Rα was robustly expressed on cultured CD11c + dendritic cells (DCs), and surprisingly also on Th1-skewed CD4 T cells (Fig. 4A) . However, IL-15Rα was conspicuously absent on Th17 cells (Fig. 4A) . ELISA for soluble IL-15Rα proteins also showed that Th17 cells did not secrete IL-15Rα, whereas Th1 cells expressed large amounts of soluble IL-15Rα (Fig. 4B) . Importantly, even as Th1 cells produced both membrane and soluble IL-15Rα, they did not transpresent IL-15 as illustrated by the lack of anti-IL-15 surface staining of in vitro differentiated Th1 cells (Fig. 4C) . The same was the case for 
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Th17 cells (Fig. 4C) . Collectively, these results documented that Th17 cells neither express nor secrete IL-15Rα, and thus exclude Th17 cells as a source for IL-15 trans-presentation.
To further examine the importance of IL-15 trans-presentation, we stimulated CD4 T cells with recombinant IL-15 alone or with IL-15 complexed to IL-15Rα under Th17-skewing conditions. In stark contrast to IL-15 alone which had no effect, we found that IL-15 trans-presented by IL-15Rα induced a marked reduction of IL-17 expression in CD4 T cells (Fig. 4D) . Thus, these results formally establish that IL-15 can suppress IL-17 expression in CD4 effector T cells, and that IL-15 bioactivity requires trans-presentation by IL-15Rα. Collectively, these data unveil distinct downstream effects of free versus IL-15Rα-bound IL-15 in controlling CD4 effector T cell function.
IL-15 trans-presented by IL-15Rα promotes Foxp3 + Treg cells generation in vitro
To further determine the importance of IL-15Rα in establishing IL-15 bioactivity, we examined IL-2Rβ/γc signaling upon IL-2, IL-15, and IL-15/IL-15Rα stimulation. To this end, we activated CD4 LN T cells overnight with plate-bound anti-CD3/CD28 antibodies, rested them in fresh media for 16 h, and then analyzed cytokine signaling by assessing STAT5 phosphorylation. Activated CD4 T cells expressed large amounts of surface IL-2Rβ and γc (Fig. 5A) , and showed robust STAT5 phosphorylation upon cytokine stimulation (Fig. 5B) . Notably, IL-2 and IL-15 did not differ in their potency to induce pSTAT5, suggesting that these cytokines are equally effective to trigger proximal IL-2Rβ/γc signaling. Interestingly, complexing IL-15 to IL-15Rα did not further increase pSTAT5 content relative to IL-15 alone.
To demonstrate that IL-15 can be equipotent to IL-2 when complexed with IL-15Rα, we set up in vitro Foxp3 + Treg cell differentiation cultures. IL-2 receptor signaling is a critical driver of Treg cell generation [39] , but curiously only IL-2, and not recombinant IL-15, can drive generation of mature Foxp3 + CD25 + Treg cells in vitro [40, 41] .
Because Treg cells do not produce IL-15 (Supplemental Fig. 4 (Fig. 5C ), reaffirming that IL-15
trans-presentation is required to convert IL-15 into a biologically active form that drives CD4 T cell effector differentiation.
Discussion
Effector CD4 T cells express a vast array of different cytokines to control and coordinate cellular and humoral immune responses. Here we show that IL-15 is not one of such CD4 T cell-produced cytokines. 
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Despite playing a critical role in inflammation, autoimmune diseases, and tissue immunity [7, 44] , IL-15 expression was conspicuously absent in CD4 T cells. Moreover, we did not find evidence for IL-15 gene reporter activity in terminally differentiated effector CD4 T cells. CD4 T cells also did not express IL-15Rα, the unique receptor for IL-15 that is necessary for intracellular transport and secretion of IL-15 [45, 46] . Collectively, these results argue against an autocrine role of IL-15 in CD4 effector T cells, and they suggest that immune dysregulation of IL-15-or IL-15Rα-deficient CD4 effector T cells would be mediated by T cell-extrinsic effects of IL-15-deficiency. Lack of IL-15 expression results in multiple defects in innate and adaptive immunity, including the loss of NK and iNKT cells as well as impaired survival and function of CD8 effector memory cells [9] . Generation and homeostasis of CD4 T cells remain intact in the absence of IL-15 [21] . However, recent studies reported the unexpected finding that IL-15 signaling can play a role in generation and function of CD4 effector T cells, such as in differentiation of IL-17-producing Th17 cells, in imposing Th1 lineage fate, and in immune suppression by Foxp3 + T regulatory cells [12, 26, 47] . Specifically, IL-15-and IL-15Rα-deficient CD4 T cells were more efficient in generating IL-17-producing cells under Th17 polarizing conditions, while stimulation with exogenous IL-15 potently suppressed Th17 cell differentiation in vitro [12] . Consequently, it has been proposed that IL-15 is expressed by CD4 T cells themselves to be complexed with IL-15Rα, and thus to inhibit their differentiation into Th17 cells in an autocrine fashion [12] . These results are reminiscent of Th17 cell suppression by IL-2 [23] , which shares the same IL-2Rβ/γc cytokine receptor complex with IL-15 for signaling. Therefore, Th17 suppression by IL-15 would be a logical corollary, considering that IL-2 and IL-15 bind to the same cytokine receptors and utilize a common signaling pathway in target cells [48] [49] [50] . Curiously, the same study that initially reported an IL-15 effect on Th17 cells also found that IL-15-mediated Th17 suppression was critically dependent on the anatomical location of Th17 cells [12] . As demonstrated in an in vivo EAE model with IL-15-deficient mice, only activated CD4 T cells in the draining LN, but not in the spleen, were receptive to IL-15-mediated suppression of IL-17 expression [12] . These results suggested that factors other than CD4 T cell-intrinsic IL-15 would be required and contribute to the inhibitory effect of IL-15 on Th17 differentiation. In agreement, recent analysis of IL-15 transgenic mice (IL-15 Tg ) underscored the Th17 suppressive function of IL-15 being dependent on the local tissue environment [51] . The IL-15 transgene is driven by a universal promoter/enhancer [52] , so that in IL-15 Tg mice, all CD4 effector T cells are converted into IL-15 producers.
However, decreased frequencies of Th17 cells were only observed among CD4 T cells in the small intestine lamina propria (LP), and not in the spleen. These results indicated that IL-15 from the tissue environment can mediate suppression of Th17 cells, but that autocrine CD4 T cell-intrinsic IL-15 was not sufficient to do so [13] . We propose that a likely mechanism behind this observation would be the requirement for IL-15Rα, which binds to and complexes with IL-15 for trans-presentation to IL-2Rβ/γc on target cells.
IL-15 trans-presentation by IL-15Rα is an important mechanism of IL-15 signaling in vivo [53] , and multiple studies have demonstrated that IL-15Rα expression is dispensable on target cells but required on IL-15-producing neighboring cells for effective IL-15 signaling in trans. Notably, IL-15Rα is mostly expressed in cells of non-lymphoid tissues, such as lung, liver, muscle and endothelial cells [35, 54, 55] . Increased IL-15Rα availability in the gut would explain the selective decrease of Tg Th17 cells in the small intestine LP, and the failure to suppress Th17 differentiation in the spleen [51] . Along these lines, IL-15/IL-15Rα signaling in the gut would also contribute to the differentiation and maintenance of Foxp3 + Treg cells, thus creating an overall immune suppressive environment that promotes intestinal Treg cell homeostasis but suppresses pro-inflammatory Th17 cell differentiation. In fact, loss of intestinal IL-15 signaling results in downregulation of Foxp3 expression and triggers inflammatory bowel disease that was associated with enhanced RORγt expression and accumulation of Th17 cells [26] . Thus, intestinal IL-15 plays a dual role for Foxp3 + Treg and Th17 cells to maintain immune quiescence in the gut.
Here we wish to emphasize that we found Th17 CD4 effector T cells being absent for IL-15Rα expression. IL-15Rα is produced both as a conventional membrane-bound form and a secreted form, whereby the soluble IL-15Rα is thought to be generated by proteolytic cleavage of the membrane form [56] . Notably, complexing IL-15 with soluble IL-15Rα conferred bioactivity to IL-15 that altered CD4 effector cell generation. Thus, the lack of IL-15Rα expression on CD4 T cells explains the inability of free IL-15 to suppress Th17 cell differentiation and the failure to induce Foxp3 + Treg cell generation in vitro when using purified naïve CD4 T cells for stimulation. IL-15 trans-presentation by IL-15Rα has been considered a vital mechanism for efficient IL-15 signaling because IL-15-and IL-15Rα-deficient mice display largely overlapping phenotypes [9, 31] . The pre-association of IL-15 with IL-15Rα, and the trans-presentation of IL-15 in context of IL-15Rα could be important for multiple reasons, such as to prevent degradation and excretion of circulating IL-15 or concentrating IL-15 to the cell surface for localized and higher density signaling [53] . Without physiological data that can clarify the differences between free IL-15 and IL-15Rα-complexed IL-15 binding to IL-2Rβ/γc, however, it remains difficult to provide a rationale why IL-15/IL-15Rα complexes would be superior in signaling compared to unbound IL-15. Because both free and IL-15Rα-bound IL-15 induced robust STAT5 phosphorylation in CD4 T cells, we propose that it is not quantitative, but possibly kinetic differences that determine IL-15 bioactivity to control effector T cell differentiation. As a corollary, we further conjecture that distinct downstream effects of IL-15 and IL-2, which utilize the same IL-2Rβ/γc complex for signaling but induce quite different cellular outcomes, could also be the results from differences in their signaling kinetics. IL-2Rβ/γc signaling induces CD25 (IL-2Rα) expression on the same cells, which potentiates and increases IL-2 binding and signaling. Mechanistically, the difference in free versus IL-15Rα-trans-presented IL-15 signaling might reside in the distinct signaling kinetics of these two forms of IL-15. Earlier studies demonstrated that IL-15Rα-associated IL-15 induced prolonged and persistent downstream signaling, whereas signaling by IL-15 alone was equally strong as IL-15Rα-complexed IL-15 but rapidly declined [30, 57] . In addition to higher binding affinity toward the receptor [35, 36] , internalization and recycling of the IL-15/IL-15Rα complex is proposed to be another key mechanism that prolongs IL-15 signaling in responder cells and can explain the difference between free and trans-presented IL-15 [58] . Whether such difference in signaling kinetics is indeed the molecular basis for distinct bioactivity between free IL-15 and IL-15Rα-complexed IL-15 is an attractive idea that will be pursued in future studies.
In conclusion, here we demonstrated a role for IL-15 in CD4 effector cells, specifically during pro-inflammatory Th17 cell differentiation, and we revealed an critical requirement for IL-15Rα and for IL-15 transpresentation in this process. Because we found IL-15 being not produced by CD4 T cells, we also exclude both autocrine and paracrine effects of IL-15 in CD4 T cells. IL-15 shares and co-utilizes the IL-2Rβ/γc cytokine receptor complex with IL-2, so that the inability of CD4 T cells to produce IL-15 could be a developmentally set mechanism to ensure effective IL-2 signaling during effector cell generation and differentiation.
Conclusions
Stimulation with free IL-15 induced STAT5 phosphorylation but failed to control effector cell differentiation of CD4 T cells. IL-15-bound to soluble IL-15Rα, on the other hand, was effective for both proximal signaling and effector CD4 T cell differentiation. Thus, the current study provides new mechanistic insights into the biological function of IL-15 in CD4 effector cell generation, and puts forward IL-15 trans-presentation as a critical mechanism to control the pro-versus anti-inflammatory effects of IL-15.
